Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Steps in Outbreak Investigation

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Machine learning for predicting surgical difficulty of laparoscopic total mesorectal excision for rectal cancer: integrating MR-based pelvimetry and peritoneal reflection.

Frontiers in medicine·2026

Same author

Genome-Wide Analysis of <i>PP2C</i> Gene Family and Identification of <i>DlPP2C1</i> as an ABA-Responsive Candidate Regulator During Early Somatic Embryogenesis in Longan (<i>Dimocarpus longan</i> Lour.).

Plants (Basel, Switzerland)·2026

Same author

Developing an expanded version of My Diabetes Care in English and Spanish: A design and formative usability study.

Digital health·2026

Same author

Physiological and cellular basis of inter-species variation in freeze tolerance between Bombyx mori and Antheraea pernyi.

Cryobiology·2026

Same author

High barrier paper coating with dual-crosslinked networks based on cellulose nanofibrils and epoxidized natural rubber.

International journal of biological macromolecules·2026

Same author

CD98hc controls CNS angiogenesis and blood-brain barrier integrity through localized regulation of the systemic integrin-FAK pathway.

Nature cardiovascular research·2026

Same journal

Sensitivity Analyses of a Scoring System for a Contraception Decision Aid.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026

Same journal

Improving electronic health record processing of large language models via retrieval-augmented generation: A case study on dietary supplements.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026

Same journal

Developing a User-Centered Mobile Application Prototype: Bridging Lower-Limb Fracture Care from Skilled Nursing Facility and Back to the Community.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026

Same journal

KERAP: A Knowledge-Enhanced Reasoning Approach for Accurate Zero-shot Diagnosis Prediction Using Multi-agent LLMs.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026

Same journal

Automating Adjudication of Cardiovascular Events Using Large Language Models.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026

Same journal

Predictive Factors and State-Level Barriers to Postpartum Birth Control Usage in the United States: Insights from PRAMS Phase 8.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026

See all related articles

Search research articles

Related Experiment Videos

Type 2 diabetes risk forecasting from EMR data using machine learning.

Subramani Mani¹, Yukun Chen, Tom Elasy

¹Department of Medicine, University of New Mexico, Albuquerque, NM 87131, USA.

AMIA ... Annual Symposium Proceedings. AMIA Symposium

|January 11, 2013

Summary

This summary is machine-generated.

Electronic medical records can effectively forecast type 2 diabetes (T2D) risk up to a year in advance using machine learning. This feasibility study shows potential for early intervention through lifestyle changes.

Related Experiment Videos

Area of Science:

Biomedical Informatics
Data Science in Healthcare
Predictive Analytics

Background:

Electronic Medical Records (EMR) contain vast patient data.
Predicting Type 2 Diabetes (T2D) risk is crucial for preventative care.
Developing accurate forecasting models is an ongoing challenge.

Purpose of the Study:

To evaluate the feasibility of using EMR data for T2D risk forecasting.
To develop and test machine learning models for predicting T2D onset.
To assess the predictive accuracy of models for T2D development.

Main Methods:

Utilized demographic, clinical, and laboratory data from over 2,000 patients in EMR.
Applied various machine learning algorithms to analyze patient data.
Assessed the risk of developing T2D between six months and one year post-analysis.

Main Results:

Achieved an Area Under the Curve (AUC) greater than 0.8.
Successfully predicted T2D risk 365 days prior to diagnosis.
Demonstrated predictive capability 180 days before T2D diagnosis.

Conclusions:

EMR data is feasible for T2D risk forecasting.
Machine learning models can identify high-risk populations.
Early identification enables timely lifestyle intervention to prevent or delay T2D.